Quinoline derivative for use in the treatment and prevention of viral infections
The present invention relates to a quinoline derivative of formula (1) or one of its pharmaceutically acceptable salts. The present invention further relates to said quinoline derivative for medicament and for use in the treatment or prevention of a viral or retroviral infection and in particular AIDS or an AIDS-related condition or Human Immunodeficiency virus (HIV). The present invention also relates to a pharmaceutical composition comprising said quinoline derivative and to the process for preparing it as to a novel intermediate compound.
1. A quinoline derivative of formula (1)
or a pharmaceutically acceptable salt thereof.
2. A pharmaceutical composition comprising the quinoline derivative according to claim 1 and at least one pharmaceutically acceptable excipient.
3. A medicament comprising the quinoline derivative according to claim 1 .
4. A process for preparing a quinoline derivative, comprising a step of treating compound (4)
in a solution of lithium hydroperoxide, thereby forming a quinoline derivative of formula (1)
5. The process of claim 4 , wherein, before treating compound (4) in a solution of lithium hydroperoxide, reacting formula (2)
with a compound of formula (3):
in the presence of a heavy metal salt and solvent thereby forming compound (4).
6. A compound of formula (4)
or a pharmaceutically acceptable salt thereof.
7. A method for treating or reducing likelihood of occurrence or re-occurrence, of a human immunodeficiency virus (HIV) infection or of acquired immune deficiency (AIDS), comprising administering to a subject a quinoline derivative of formula (1)
or a pharmaceutically acceptable salt thereof.
8. The method of claim 7 , wherein the method is for treating AIDS.
9. The method of claim 7 , wherein the method is for treating a HIV infection.
10. The method of claim 7 , wherein the method is for treating a human immunodeficiency virus (HIV) infection, or AIDS.